Evidence map›Paper›PMID 35150915›Full record

ArticleInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases2022

Cytomegalovirus infections in infants in Uganda: Newborn-mother pairs, neonates with sepsis, and infants with hydrocephalus.

Christine Hehnly, Paddy Ssentongo, Lisa M Bebell, Kathy Burgoine, Joel Bazira, Claudio Fronterre, Elias Kumbakumba, Ronald Mulondo, Edith Mbabazi-Kabachelor, Sarah U Morton and 16 more

Open access · goldAbstract read
In one paragraph

Article in International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 5 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 10 institutions in 3 countries.

Christine HehnlyInstitute for Personalized Medicine, Department of Biochemistry and Molecular Biology, The Pennsylvania State University College of Medicine, Hershey, PA, USA.
Paddy SsentongoCenter for Neural Engineering, Department of Engineering Science and Mechanics, The Pennsylvania State University, University Park, PA, USA; Department of Public Health Sciences, The Pennsylvania State University College of Medicine, Hershey, PA, USA.
Lisa M BebellDepartment of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Kathy BurgoineNeonatal Unit, Department of Paediatrics and Child Health, Mbale Regional Referral Hospital, Mbale, Uganda; Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom; Mbale Clinical Research Institute, Mbale Regional Referral Hospital, Mbale, Uganda.
Joel BaziraDepartment of Microbiology, Mbarara University of Science and Technology, Mbarara, Uganda.
Claudio FronterreCentre for Health Informatics, Computing, and Statistics, Lancaster University, Lancaster, United Kingdom.
Elias KumbakumbaDepartment of Pediatrics, Mbarara University of Science and Technology, Mbarara, Uganda.
Ronald MulondoCURE Children's Hospital of Uganda, Mbale, Uganda.
Edith Mbabazi-KabachelorCURE Children's Hospital of Uganda, Mbale, Uganda.
Sarah U MortonDivision of Newborn Medicine, Boston Children's Hospital and Department of Pediatrics, Harvard Medical School, Boston, MA, USA.
Joseph NgonziDepartment of Obstetrics and Gynaecology, Mbarara University of Science and Technology, Mbarara, Uganda.
Moses OchoraCentre for Health Informatics, Computing, and Statistics, Lancaster University, Lancaster, United Kingdom.
Peter Olupot-OlupotMbale Clinical Research Institute, Mbale Regional Referral Hospital, Mbale, Uganda; Busitema University, Busitema, Uganda.
John MugambaCURE Children's Hospital of Uganda, Mbale, Uganda.
Justin OnenMulago National Referral Hospital, Kampala, Uganda.
Drucilla J RobertsDepartment of Pathology, Massachusetts General Hospital, Boston, and Harvard Medical School, Boston, MA, USA.
Kathryn SheldonInstitute for Personalized Medicine, Department of Biochemistry and Molecular Biology, The Pennsylvania State University College of Medicine, Hershey, PA, USA.
Shamim A SinnarDepartment of Medicine, The Pennsylvania State University College of Medicine, Hershey, PA, USA.
Jasmine SmithInstitute for Personalized Medicine, Department of Biochemistry and Molecular Biology, The Pennsylvania State University College of Medicine, Hershey, PA, USA.
Peter SsenyongaMulago National Referral Hospital, Kampala, Uganda.
Julius KiwanukaDepartment of Pediatrics, Mbarara University of Science and Technology, Mbarara, Uganda.
Joseph N PaulsonDepartment of Biostatistics, Product Development, Genentech Inc., San Francisco, CA, USA.
Frederick A MeierWayne State University School of Medicine, Detroit, MI, USA.
Jessica E EricsonDivision of Pediatric Infectious Disease, The Pennsylvania State University College of Medicine, Hershey, PA, USA.
James R BroachInstitute for Personalized Medicine, Department of Biochemistry and Molecular Biology, The Pennsylvania State University College of Medicine, Hershey, PA, USA.
Steven J SchiffCenter for Neural Engineering, Department of Engineering Science and Mechanics, The Pennsylvania State University, University Park, PA, USA; Center for Infectious Disease Dynamics, and Department of Physics, The Pennsylvania State University, University Park, PA, USA; Department of Neurosurgery, The Pennsylvania State University College of Medicine, Hershey, PA, USA. Electronic address: steven.j.schiff@gmail.com.
Pennsylvania State University · USMbarara University of Science and Technology · UGCURE Children’s Hospital of Uganda · UGHarvard University · USLancaster University · GBMulago Hospital · UGBoston Children's Hospital · USMbale Hospital · UGUniversity of Liverpool · GBWayne State University · US

Funding

Genetic Analysis and Manipulation Core (GAEC)P50HD105351 · NICHD · BOSTON CHILDREN'S HOSPITAL · PI Hisashi Umemori · 2021 to 2026
$9.4M
Predictive Personalized Public Health (P3H): A Novel Paradigm to Treat Infectious DiseaseR01AI145057 · NIAID · YALE UNIVERSITY · PI SCHIFF, STEVEN J · 2018 to 2022
$8.1M
Control of the Neonatal Septisome and Hydrocephalus in sub-Saharan AfricaDP1HD086071 · NICHD · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI SCHIFF, STEVEN J · 2015 to 2019
$4.1M
Improving infant hydrocephalus outcomes in Uganda: Predicting developmental outcomes and identifying patients at risk for early treatment failure after ETV/CPCR01HD096693 · NICHD · BOSTON CHILDREN'S HOSPITAL · PI LIN, PEI-YI, WARF, BENJAMIN CURTIS · 2018 to 2022
$2.8M
Development and Evaluation of Diffuse Correlation Spectroscopy to Monitor Cerebral Blood Flow and Detect Intraventricular Hemorrhage in Extremely Premature InfantsR42NS110337 · NINDS · 149 MEDICAL INC. · PI INDER, TERRIE E, ZIMMERMANN, BERNHARD · 2019 to 2022
$774k
NIAID NIH HHS R01 AI145057NICHD NIH HHS DP1 HD086071NICHD NIH HHS P50 HD105351NICHD NIH HHS R01 HD096693NINDS NIH HHS R42 NS110337
6 · The paper itself

Abstract

objectivesTo estimate the prevalence of cytomegalovirus (CMV) infections among newborn-mother pairs, neonates with sepsis, and infants with hydrocephalus in Uganda. DESIGN AND

methodsThree populations-newborn-mother pairs, neonates with sepsis, and infants (≤3 months) with nonpostinfectious (NPIH) or postinfectious (PIH) hydrocephalus-were evaluated for CMV infection at 3 medical centers in Uganda. Quantitative PCR (qPCR) was used to characterize the prevalence of CMV.

resultsThe overall CMV prevalence in 2498 samples across all groups was 9%. In newborn-mother pairs, there was a 3% prevalence of cord blood CMV positivity and 33% prevalence of maternal vaginal shedding. In neonates with clinical sepsis, there was a 2% CMV prevalence. Maternal HIV seropositivity (adjusted odds ratio [aOR] 25.20; 95% confidence interval [CI] 4.43-134.26; p = 0.0001), residence in eastern Uganda (aOR 11.06; 95% CI 2.30-76.18; p = 0.003), maternal age <25 years (aOR 4.54; 95% CI 1.40-19.29; p = 0.02), and increasing neonatal age (aOR 1.08 for each day older; 95% CI 1.00-1.16; p = 0.05), were associated risk factors for CMV in neonates with clinical sepsis. We found a 2-fold higher maternal vaginal shedding in eastern (45%) vs western (22%) Uganda during parturition (n = 22/49 vs 11/50, the Fisher exact test; p = 0.02). In infants with PIH, the prevalence in blood was 24% and in infants with NPIH, it was 20%. CMV was present in the cerebrospinal fluid (CSF) of 13% of infants with PIH compared with 0.5% of infants with NPIH (n = 26/205 vs 1/194, p < 0.0001).

conclusionsOur findings highlight that congenital and postnatal CMV prevalence is substantial in this African setting, and the long-term consequences are uncharacterized.

Indexed as

Cytomegalovirus InfectionsHydrocephalusSepsisAdultFemaleHumansInfantInfant, NewbornRisk FactorsUgandacytomegalovirus infectionhydrocephalusneonatal sepsissub-Saharan Africa

Identifiers

PMID35150915
PMCPMC9058984
OpenAlexW4212962534

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.